{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T19:27:08Z","timestamp":1781983628025,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.clinre.2017.02.005","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T21:17:54Z","timestamp":1490735874000},"page":"554-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients"],"prefix":"10.1016","volume":"41","author":[{"given":"Haiyun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangmin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Side","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2017.02.005_bib0205","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2017.02.005_bib0210","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"Suppl. 3","key":"10.1016\/j.clinre.2017.02.005_bib0215","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/S1590-8658(10)60507-5","article-title":"The changing pattern of epidemiology in hepatocellular carcinoma","volume":"42","author":"Nordenstedt","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2017.02.005_bib0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000218339","article-title":"Hepatocellular carcinoma\u00a0\u2013\u00a0epidemiological trends and risk factors","volume":"27","author":"Schutte","year":"2009","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2017.02.005_bib0225","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"European Association for the Study of the Liver. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2017.02.005_bib0230","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1016\/S0021-9258(17)37580-4","article-title":"PKCu is a novel, atypical member of the protein kinase C family","volume":"269","author":"Johannes","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2017.02.005_bib0235","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1073\/pnas.91.18.8572","article-title":"Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain","volume":"91","author":"Valverde","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinre.2017.02.005_bib0240","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1074\/jbc.M008719200","article-title":"Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases","volume":"276","author":"Sturany","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2017.02.005_bib0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-4889(99)00040-3","article-title":"PKCnu, a new member of the protein kinase C family, composes a fourth subfamily with PKCmu","volume":"1450","author":"Hayashi","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinre.2017.02.005_bib0250","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/1535-7163.MCT-13-0880","article-title":"Protein kinase d as a potential chemotherapeutic target for colorectal cancer","volume":"13","author":"Wei","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.clinre.2017.02.005_bib0255","first-page":"183","article-title":"Protein kinase D as a potential new target for cancer therapy","volume":"1806","author":"LaValle","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinre.2017.02.005_bib0260","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.bcp.2010.07.002","article-title":"Role of protein kinase D signaling in pancreatic cancer","volume":"80","author":"Guha","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinre.2017.02.005_bib0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/emboj\/cdg009","article-title":"Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway","volume":"22","author":"Storz","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.clinre.2017.02.005_bib0270","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cub.2004.01.003","article-title":"Protein kinase D-mediated anterograde membrane trafficking is required for fibroblast motility","volume":"14","author":"Prigozhina","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.clinre.2017.02.005_bib0275","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/1535-7163.MCT-14-0945","article-title":"Effective targeting of estrogen receptor-negative breast cancers with the protein kinase D inhibitor CRT0066101","volume":"14","author":"Borges","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.clinre.2017.02.005_bib0280","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/carcin\/bgm291","article-title":"Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion","volume":"29","author":"Kim","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clinre.2017.02.005_bib0285","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1091\/mbc.e13-06-0334","article-title":"Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases","volume":"25","author":"Wille","year":"2014","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.clinre.2017.02.005_bib0290","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/gut.2009.206813","article-title":"Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours","volume":"59","author":"Azoitei","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2017.02.005_bib0295","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1158\/0008-5472.CAN-07-5156","article-title":"Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon\/PKD3 pathway downstream of Akt and ERK 1\/2","volume":"68","author":"Chen","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinre.2017.02.005_bib0300","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1158\/1078-0432.CCR-10-0331","article-title":"ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth","volume":"17","author":"Liu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinre.2017.02.005_bib0305","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clinre.2017.02.005_bib0310","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1053\/j.gastro.2011.12.039","article-title":"Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival","volume":"142","author":"Roessler","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2017.02.005_bib0315","doi-asserted-by":"crossref","first-page":"524","DOI":"10.18632\/oncotarget.6358","article-title":"Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clinre.2017.02.005_bib0320","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/jcp.2007.046987","article-title":"Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability","volume":"61","author":"Al-Mulla","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clinre.2017.02.005_bib0325","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1756-9966-31-30","article-title":"Prognostic value of RKIP and p-ERK in gastric cancer","volume":"31","author":"Fujimori","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.clinre.2017.02.005_bib0330","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.2147\/OTT.S103141","article-title":"PinX1 suppresses tumorigenesis by negatively regulating telomerase\/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis","volume":"9","author":"Qian","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.clinre.2017.02.005_bib0335","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1535-7163.MCT-11-0887","article-title":"Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer","volume":"11","author":"LaValle","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.clinre.2017.02.005_bib0340","first-page":"4800","article-title":"PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-kappaB- and HDAC1-mediated expression and activation of uPA","volume":"125","author":"Zou","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.clinre.2017.02.005_bib0345","doi-asserted-by":"crossref","first-page":"e75601","DOI":"10.1371\/journal.pone.0075601","article-title":"New pyrazolopyrimidine inhibitors of protein kinase d as potent anticancer agents for prostate cancer cells","volume":"8","author":"Tandon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2017.02.005_bib0350","doi-asserted-by":"crossref","first-page":"33516","DOI":"10.1074\/jbc.M805358200","article-title":"Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone","volume":"283","author":"Sharlow","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2017.02.005_bib0355","first-page":"393","article-title":"Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells","volume":"33","author":"Hao","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clinre.2017.02.005_bib0360","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1074\/jbc.M113.502633","article-title":"Elevated protein kinase D3 (PKD3) expression supports proliferation of triple-negative breast cancer cells and contributes to mTORC1-S6K1 pathway activation","volume":"289","author":"Huck","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2017.02.005_bib0365","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-5793(03)00487-3","article-title":"Protein kinase D: a family affair","volume":"546","author":"Rykx","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinre.2017.02.005_bib0370","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tips.2006.04.003","article-title":"PKD at the crossroads of DAG and PKC signaling","volume":"27","author":"Wang","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.clinre.2017.02.005_bib0375","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/iub.456","article-title":"Protein kinase D in vascular biology and angiogenesis","volume":"63","author":"Evans","year":"2011","journal-title":"IUBMB Life"},{"key":"10.1016\/j.clinre.2017.02.005_bib0380","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2017.02.005_bib0385","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00535-005-1566-3","article-title":"Updated treatment approach to hepatocellular carcinoma","volume":"40","author":"Llovet","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.clinre.2017.02.005_bib0390","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1073\/pnas.56.3.1010","article-title":"Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin)","volume":"56","author":"Goldstein","year":"1966","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinre.2017.02.005_bib0395","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s11605-014-2596-z","article-title":"Expression of bile duct transcription factor HNF1beta predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma","volume":"18","author":"Yuan","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.clinre.2017.02.005_bib0400","doi-asserted-by":"crossref","first-page":"e70324","DOI":"10.1371\/journal.pone.0070324","article-title":"Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740117300761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740117300761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:26:11Z","timestamp":1761895571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740117300761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2210740117300761"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2017.02.005","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2017.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}